Cervical cancer prevention in HIV-infected women in resource-limited settings

HIV Therapy

Volumn 4, Issue 6, 2010, Pages 625-628

  Parham, Groesbeck ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; WART VIRUS VACCINE;

CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CELLULAR IMMUNITY; CLINICAL EFFECTIVENESS; CRYOTHERAPY; DEPRESSION; GENOTYPE; HEALTH PROGRAM; HEALTH SERVICE; HETEROSEXUAL FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; NONHUMAN; NOTE; PAPILLOMAVIRUS INFECTION; POVERTY; PSYCHOPHYSIOLOGY; SELF ESTEEM; SEXUAL INTERCOURSE; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

EID: 78650584194     PISSN: 17584310     EISSN: None     Source Type: Journal    
DOI: 10.2217/hiv.10.58     Document Type: Note

References (1)

1. Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV et al.: Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther. 4(6), 713-722 (2010).